Search results
Seagen (SGEN) Posts Positive Data from New Study on Tukysa
Zacks via Yahoo Finance· 2 years agoSeagen (SGEN) reports favorable data on the pivotal phase II MOUNTAINEER study evaluating Tukysa in...
Seagen's (SGEN) Tukysa Gets Accelerated FDA Nod for New Indication
Zacks via Yahoo Finance· 1 year agoThe FDA grants accelerated approval to Seagen's (SGEN) Tukysa in combination with trastuzumab for...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 9 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
Roche (RHHBY) Q1 Revenues Decline on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 1 year agoSwiss pharma giant Roche Holding AG’s RHHBY first-quarter revenues declined 7% to CHF 15.3 billion...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Here's Why You May Invest in Puma Biotechnology (PBYI) Stock
Zacks via Yahoo Finance· 5 months agoPuma Biotechnology, Inc.PBYI is a biotechnology company focused on research in cancer. The company’s...
Jeanne Beker gets cancer treatment before winning Lifetime Achievement award
Yahoo Canada Style· 2 years agoJeanne Beker received cancer treatment before the Women Empowerment Awards. (Photo by Isaiah...
Will Seagen's (SGEN) Portfolio of Drugs Help Combat Rivalry?
Zacks via Yahoo Finance· 2 years agoSeagen (SGEN) expects its portfolio of marketed drugs, which are approved for various cancer...
Roche (RHHBY) 2023 Earnings Miss, COVID-19 Product Sales Down
Zacks via Yahoo Finance· 3 months agoRoche (RHHBY) misses earnings and sales estimates in 2023 due to a significant decline in...
Roche (RHHBY) Q1 Hit by Currency Headwinds, Lower COVID-19 Sales
Zacks via Yahoo Finance· 1 week agoRoche's (RHHBY) performance in first-quarter 2024 is pretty ho-hum as COVID-19-test sales continue...